REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN)

1,135 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2021.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,008 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 90,013,397 shares of 104,986,330 outstanding shares and own 86% of the company stock.
Largest 10 shareholders include FMR LLC (11,067,950 shares), BlackRock Inc. (9,366,861 shares), VANGUARD GROUP INC (8,071,281 shares), Capital World Investors (5,320,000 shares), STATE STREET CORP (4,640,005 shares), JPMORGAN CHASE & CO (4,102,445 shares), WELLINGTON MANAGEMENT GROUP LLP (3,368,065 shares), LOOMIS SAYLES & CO L P (2,756,735 shares), GEODE CAPITAL MANAGEMENT, LLC (1,740,212 shares), and PUTNAM INVESTMENTS LLC (1,342,754 shares).
This table shows the top 1,008 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.